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Abstract: Oxidized L-glutathione was esterified to the tetra methyl ester using thionyl
chloride in methanol solvent. Other alcohols were tested and the reaction progress was
monitored via ESI-MS. This procedure proved to be compatible with other small peptides
not containing serine and cysteine residues. In contrast to previously reported methods this
procedure provided convenient access to esterified peptides requiring no purification,
extended reaction times, or complicated reaction setups.
Keywords: esterification; peptide esterification; amino acids; carboxylic acids; esters

1. Introduction
The design and synthesis of novel glutathione analogues are studied extensively for their
pharmacological properties in the treatment of a wide range of diseases [1–3]. Reduced glutathione
(GSH), -L-glutamyl-L-cysteinyl-glycine, is prone to reactivity at the sulfhydryl, terminal amino group,
and both carbonyls. Thus, the synthesis of GSH analogues are a synthetic challenge to chemists, and the
clever manipulation of protecting groups are needed to prevent unwanted reactions. One approach to
synthesize protected GSH analogues is to start with the readily available disulfide dimmer of GSH,
L-glutathione (GSSG) 1. GSSG is affordable and the sulfhydryl functional groups are protected in their
disulfide form. 1 can be inconveniently converted to 2a by Fischer esterification [4–6] resulting in the
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protection of the carboxyl groups. In our hands the reported Fischer esterification protocol required
extensive purification and the isolated yield was too low to be of practical value. Although 2a is
commercially available the cost is quite high ($1290 per 100 mg) making direct purchase prohibitive in
many cases [7]. Additional esterification strategies include utilizing trimethylsilyl chloride in methanol
solvent [2,8] and the use of diazomethane to form methyl esters [9,10]. However, the use of diazomethane
is toxic, potentially explosive, and requires specialized glassware not readily available in all labs.
Herein, we report a convenient synthesis of 2a using thionyl chloride in methanol solvent as illustrated
in Scheme 1. Surprisingly, this method eliminated side reactions, long reaction times, and column
purification. Furthermore, we extended the method to other peptides in order to gain an understanding
of the compatibility with other protogenic amino acids. The ease with which peptide esters are formed
could be an invaluable tool for peptide mass spectrometry [3,11–13] as the protected carboxylic acid
enhances signal intensity.
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Scheme1. Preparation of oxidized glutathione tetra-alkyl esters (GSSG(OR)4) from oxidized
glutathione (GSSG) using thionyl chloride in alcohol solvent.
2. Results and Discussion
The esterification of oxidized glutathione (GSSG) with thionyl chloride was previously
reported [14], but studies monitoring the reaction conversion have not been reported. The disposition
toward thionyl chloride acylation is likely due to the incompatibilities often associated with the harsh
conditions of thionyl chloride which are subject to both side reactions and incomplete formation of
product. Therefore, we set out to study the limitations of this method by monitoring the reaction using
ESI-MS in the presence of various alcohols using 1 as a substrate.
The reactions were performed on 250 mg of GSSG in 50 mL of anhydrous alcohol. To this solution
2.5 mL of thionyl chloride was added slowly and placed into a refrigerator at 4 °C. At various time
intervals a 1.0 mL aliquot was taken, concentrated under reduced pressure, suspended into 1% acetic
acid solution (50% methanol/water), and analyzed via ESI-MS. The relative intensities of the m/z for the
tetra-ester were plotted as a percentage of ester products as illustrated in Figure 1. The procedure worked
well in methanol solvent reaching completion within 16 h. The same experimental conditions were
applied using an excess of anhydrous ethanol resulting in complete conversion to 2b in 144 h. In contrast,
when the same experimental conditions were applied using an excess of anhydrous isopropyl alcohol
only a 14% conversion to 2c was realized along with significant formation of various unidentified
side products. We therefore concluded that studying other 2° or even 3° alcohols would likely not
be productive.
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(a)

(b)

Figure 1. (a) Plot of the percent conversion to the GSSG tetra esters vs. time in methanol as
determined by ESI-MS (b) Plot of the percent conversion to the GSSG tetra esters vs. time
in ethanol as determined by ESI-MS.
To further demonstrate the utility of this method the reaction conditions were applied to other small
peptides as shown in Table 1. These peptides were chosen based on comparable size to GSSG and the
coverage of amino acids present in their sequences. The reactions were performed on a 1.0 µmol scale
and immediately concentrated following a 24 h incubation at 4 °C. The peptides were then immediately
analyzed via ESI-MS.
Table 1. Peptides subjected to the thionyl chloride esterification with methanol and analyzed
via ESI-MS.
Peptide a
L-glutathione

oxidized
reduced
Fibronectin Analog
Bradykinin (1–7)
Necrofibrin, rat
[D-Ala2,D-Met5]-Enkephalin
Angiotensin II, human
Thymopentin (TP-5)
Neurotensin (9–13)
[Ile3]-Pressinoic acid

L-glutathione

Peptide
Sequence
2QCG b
QCG
GRADSPK
RPPGFSP
WTVPTA
YAGFM
DRVYIHPF
RKDVY
RPYIL
CYIQNC b

Product
Entry
2
3
4
5
6
7
8
9
10
11

Complete
Conversion
Yes
No
No
No
No
No
Yes
Yes
Yes
No

Estimated % c
Conversion
100% d
26%
23%
63%
64%
90%
100%
100%
100%
94%

a

Reaction conditions of the peptides were run using 3.44 M thionyl chloride in methanol at 4 °C for 24 h;
Peptide contains a disulfide bridge between the two cysteine residues; c Yields estimated by taking the sum
or relative intensities of all product peaks over the total relative intensities observed in ESI-MS in excess of
5% relative abundance; d isolated product yield.

b

The reactions listed in Table 1 proceeded smoothly under the esterification protocol in most cases.
However, the peptides containing serine, fibronectin and bradykinin, appear to have been converted to
the esterified alkyl chloride derivative at the serine residue [15–17]. This is evidenced by the m/z
corresponding to the molecular formula of the esterified peptide with chlorine replacing the hydroxyl
functional group and the signature isotopic ratio of chlorine. These results are not unexpected
considering that thionyl chloride is used to transform primary alcohols into alkyl chlorides. However,
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we did observe the esterified product containing the unaltered serine residue as a minor constituent in
the product mixture. Interestingly, the threonine containing peptide, necrofibrin, underwent smooth
conversion to the ester without converting the 2° alcohol into an alkyl chloride. The phenol functional
group of tyrosine in [DAla2,DMet5]-Enkephalin, Angiotensin II, Thymopentin (TP-5), and Neurotensin
(9–13) did not interfere with the esterification procedure.
The free sulfhydryl of the cysteine residue also proved to be problematic when subjected to the
esterification protocol. Reduced L-glutathione was subjected to the reaction conditions producing the
desired esterified peptide as a minor constituent. The reaction mixture contained significant quantities
of 2 and several other unidentified species by ESI-MS analysis. However, the methionine residue of
Enkephalin and the disulfide bond of [Ile3]-Pressinoic acid and GSSG were cleanly converted to their
respective esters. In addition, the residues of aspartic acid and glutamic acid were converted to their
respective methyl esters as expected. Despite these limitations all of the other protogenic amino acids
withstood the reaction conditions and were easily isolated and characterized without the need for
extensive purification.
3. Experimental Section
3.1. General Experimental
NMR spectra were acquired on a Bruker 400 MHz NMR in proton decoupled mode. The internal
standard used in the NMR experiment was the residual solvent signal for CD3OD. ESI MS was carried
out on a ThermoFisher LXQ ESI-Ion trap mass spectrometer using Optima LCMS grade methanol and
water from Fisher Scientific. The methanol used for the esterification reactions was distilled from
calcium hydride, absolute ethanol was stored over molecular sieves, and 2-propanol distilled from
sodium prior to use. L-oxidized glutathione and reduced glutathione were obtained from Sigma-Aldrich.
All other peptides were acquired from the American Peptide Company and used as received. Peptides
furnished with Certificate of Analysis (COA) contained trace impurities and those masses were provided
courtesy of American Peptide Company. Mass spectra and NMR spectra can be found in the
supplementary materials section.
3.2. Synthesis of GSSG and GSH Peptides in Alcohol Solutions
3.2.1. Synthesis of Compound 2
In a 125 mL Erlenmeyer flask, 0.250 g of L-oxidized glutathione (0.408 mmol) was added to 50 mL
of freshly distilled methanol and capped with a rubber septum. The contents were placed into an ice bath
and allowed to cool to 0 °C. The addition of 2.5 mL of thionyl chloride (34.4 mmol) was by syringe, the
flask was swirled, and placed into a refrigerator at 4 °C. After 24 h the reaction was concentrated under
reduced pressure resulting in 0.272 g of product (100% yield).The product was analyzed via ESI MS.
ESI MS of [M + H]+ calculated [C24H44N6O12S2]+, 669.22, found 669.2. 1H-NMR (400MHz, CD3OD)
δ = 4.67 (m, 2H), 4.05 (m, 2H), 3.88 (s, 4H), 3.76 (s, 6H), 3.62 (s, 6H), 3.21 (s, 4H), 2.93–2.81 (m, 2H),
2.49 (m, 4H), 2.12 (m, 4H) and 13C-NMR (100MHz, CD3OD) δ = 174.3, 173.0, 171.6, 170.7, 54.0, 53.9,
53.7, 52.8, 42.0, 41.4, 32.3, 27.0. Spectra are consistent with published data [18].
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3.2.2. Synthesis of Compound 2b
In a 125 mL Erlenmeyer flask, 0.250 g of L-oxidized glutathione (0.408 mmol) was added to 50 mL
of absolute ethanol and capped with a rubber septum. The contents were placed into an ice bath and
allowed to cool to 0 °C. The addition of 2.5 mL of thionyl chloride (34.4 mmol) was by syringe, the
flask was swirled, and placed into a refrigerator at 4 °C. After 24 h the reaction was concentrated under
reduced pressure resulting in 0.295 g of product (100% yield). The solid was taken and characterized by
ESI-MS. ESI-MS of [M + H]+ calculated [C28H44N6O12S2]+, 725.28, found 725.25. 1H-NMR (400 MHz,
CD3OD) δ = (400 MHz, MeOD) δ 4.78 (dd, J = 9.6, 4.6 Hz, 2H), 4.33 (q, J = 7.1 Hz, 4H), 4.19 (q,
J = 7.1 Hz, 4H),4.13(m, 2H), 3.97 (d, J = 2.2 Hz, 4H), 3.28 (dd, J = 14.0, 4.6 Hz, 2H), 2.99 (dd, J = 13.9,
9.7 Hz, 2H), 2.61 (t, J = 7.1 Hz, 4H), 2.23 (m, J = 21.7, 14.6, 7.5 Hz, 4H), 1.35 (t, J = 7.1 Hz, 6H), 1.28
(t, J = 7.2 Hz, 6H).13C-NMR (100MHz, CD3OD) δ =174.4, 173.0, 171.1, 170.2, 63.4,62.4, 53.9,53.7,
42.1, 41.3, 32.6, 27.0, 14.5, 14.43. Spectra are consistent with published data [19].
3.2.3. Synthesis of Compound 2c
In a 125 mL Erlenmeyer flask, 0.250 g of L-oxidized glutathione (0.408 mmol) was added to 50 mL
of freshly distilled 2-propanol and capped with a rubber septum. The contents were placed onto an ice
bath and allowed to cool to 0 °C. The addition of 2.5 mL of thionyl chloride (34.4 mmol) was by syringe,
and the flask was swirled and placed into a refrigerator at 4 °C. After 24 h the reaction was concentrated
under reduced pressure. The resulting solid was taken and characterized by ESI-MS. ESI-MS of
[M + H]+ calculated [C32H57N6O12S2]+, 781.35, found 781.25. Expected mass not present in significant
quantities so no NMR data was recorded.
3.2.4. Synthesis of Compound 3
In a 125 mL Erlenmeyer flask, 0.250 g of L-reduced glutathione (0.813 mmol) was added to 50 mL
of freshly distilled anhydrous methanol and capped with a rubber septum. The contents were placed onto
an ice bath and allowed to cool to 0 °C. The addition of 2.5 mL of thionyl chloride (34.4 mmol) was by
syringe, and the flask was swirled and placed into a refrigerator at 4 °C. After 24 h the reaction was
concentrated under reduced pressure. The resulting solid was taken and characterized by ESI-MS.
ESI-MS of [M + H]+ calculated [C12H22N3O6S]+, 336.12, found 336.08. Sample contained multiple
impurities so no NMR analysis was performed.
3.3. General Synthesis of Peptides in Methanol Solutions
The conditions for each peptide were scaled down from the GSSG reaction study in methanol based
on the number of carboxylic acid groups present in the molecule. The amount of methanol used in the
reaction was 756 equivalents of methanol to which 105 equivalents of thionyl chloride was added for
each carboxylic acid present in the peptide. This results in a 3.44 M solution of thionyl chloride in
methanol. All reactions were performed on 1.0 mg of peptide and incubated at 4 °C for 24 h. At the end
of the incubation the crude material was concentrated and analyzed by ESI-MS.
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3.3.1. Synthesis of Compound 4
In a dry glass vial fitted with a cap 1.0 mg of Fibronectin (1 µmol) was dissolved into 83.9 µL of
anhydrous methanol (2.075 mmol) and placed in an ice bath at 0 °C. To the solution 21.0 µL of thionyl
chloride (0.289 mmol) was added slowly via syringe. The vial was shaken and placed into a refrigerator
at 4 °C. After 24 h the sample was concentrated under reduced pressure, dissolved into 1.0 mL of 1%
acetic acid in a 1:1 solution of methanol:water, and analyzed on the ESI-MS. ESI-MS of [M + H]+
calculated [C31H56N11O11]+, 758.42, found 758.42.
3.3.2. Synthesis of Compound 5
In a dry glass vial fitted with a cap 1.0 mg of Bradykinin (1 µmol) was dissolved into 40.5 µL of
anhydrous methanol and placed in an ice bath at 0 °C. To the solution 10.1 µL of thionyl chloride
(0.14 mmol) was added slowly via syringe. The vial was shaken and placed into the fridge at 4 °C. After
24 h the sample was concentrated under reduced pressure, dissolved into 1.0 mL of 1% acetic acid in a
1:1 solution of methanol:water, and analyzed on the ESI-MS. ESI-MS of [M + H]+ calculated
[C36H55N10O9]+, 771.41, found 771.38.
3.3.3. Synthesis of Compound 6
In a dry glass vial fitted with a cap 1.0 mg of necrofibrin, rat (1 µmol) was dissolved into 45.5 µL of
anhydrous methanol (1.12 mmol) and placed in an ice bath at 0 °C. To the solution 11.4 µL of thionyl
chloride (0.156 mmol) was added slowly via syringe. The vial was shaken and placed into a refrigerator
at 4 °C. After 24 h the sample was concentrated under reduced pressure, dissolved into 1.0 mL of 1%
acetic acid in a 1:1 solution of methanol:water, and analyzed on the ESI-MS. ESI-MS of [M + H]+
calculated [C33H50N7O9]+, 688.37; found 688.20.
3.3.4. Synthesis of Compound 7
In a dry glass vial fitted with a cap 1.0 mg of [DAla2,DMet5] Enkephalin (2 µmol) was dissolved
into 52.1 µL of anhydrous methanol (1.29 mmol) and placed in an ice bath at 0 °C. To the solution
13.0 µL of thionyl chloride (0.18 mmol) was slowly added via syringe. The vial was shaken and placed
into a refrigerator at 4 °C. After 24 h the sample was concentrated under reduced pressure, dissolved
into 1.0 mL of 1% acetic acid in a 1:1 solution of methanol:water, and analyzed on the ESI-MS.
ESI-MS of [M + H]+ calculated [C29H40N5O7S]+, 602.26, found 602.1.
3.3.5. Synthesis of Compound 8
In a dry glass vial fitted with a cap 1.0 mg of angiotensin II, human (1 µmol) was dissolved into
58.6 µL of anhydrous methanol (1.45 mmol) and placed in an ice bath at 0 °C. To the solution 14.6 µL
of thionyl chloride (0.20 mmol) was added slowly via syringe. The vial was shaken and placed into a
refrigerator at 4 °C. After 24 h the sample was concentrated under reduced pressure, dissolved into
1.0 mL of 1% acetic acid in a 1:1 solution of methanol:water, and analyzed on the ESI-MS. ESI-MS of
[M + H]+ calculated [C52H76N13O12]+, 1074.57, found 1074.6.
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3.3.6. Synthesis of Compound 9
In a dry glass vial fitted with a cap 1.0 mg of Thymopentin (TP-5) (1 µmol) was dissolved into
90.1 µL of anhydrous methanol (2.22 mmol) and placed in an ice bath at 0 °C. To the solution 22.5 µL
of thionyl chloride (0.289 mmol) was added slowly via syringe. The vial was shaken and placed into the
fridge at 4 °C. After 24 h the sample was concentrated under reduced pressure, dissolved into 1.0 mL of
1% acetic acid in a 1:1 solution of methanol:water, and analyzed on the ESI-MS. ESI-MS of [M + H]+
calculated [C32H54N9O9]+, 708.40, found 708.47. Masses present in starting material from COA:
341(14%), 680 (100%), 1358(8%).
3.3.7. Synthesis of Compound 10
In a dry glass vial fitted with a cap 1.0 mg of Thymopentin (TP-5) (1 µmol) was dissolved into
90.1 µL of anhydrous methanol (2.22 mmol) and placed in an ice bath at 0 °C. To the solution 22.5 µL
of thionyl chloride (0.289 mmol) was added slowly via syringe. The vial was shaken and placed into the
fridge at 4 °C. After 24 h the sample was concentrated under reduced pressure, dissolved into 1.0 mL of
1% acetic acid in a 1:1 solution of methanol:water, and analyzed on the ESI-MS. ESI-MS of
[M + H]+ calculated [C32H54N9O9]+, 708.40, found 708.47.
3.3.8. Synthesis of Compound 11
In a dry glass vial fitted with a cap 1.0 mg of [Ile3] Pressinoic Acid (1 µmol) was dissolved into
41.3 µL of anhydrous methanol (1.02 mmol) and placed in an ice bath at 0 °C. To the solution 10.3 µL
of thionyl chloride (0.14 mmol) was added slowly via syringe. The vial was shaken and placed into a
refrigerator at 4 °C. After 24 h the sample was concentrated under reduced pressure, dissolved into
1.0 mL of 1% acetic acid in a 1:1 solution of methanol:water, and analyzed on the ESI-MS. ESI-MS of
[M + H]+ calculated [C31H47N8O10S2 ]+,755.29, found 755.22.
4. Conclusions
We have prepared GSSG methyl esters in high yield requiring no purification or complex reaction
protocols. The title compound could also be prepared as the ethyl ester at the expense of increased
reaction time. Based on these findings the reaction conditions were applied to other small peptides and
found to be highly compatible with many peptide sequences. We believe this procedure will find
significant use in the area of peptide modification for both synthetic and analytical purposes.
Supplementary Materials
Supplementary materials can be accessed at: http://www.mdpi.com/1420-3049/20/06/10487/s1.
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